Cyclerion Therapeutics (CYCN) Other Non-Current Assets (2018 - 2023)
Cyclerion Therapeutics (CYCN) recorded quarterly Other Non-Current Assets of $1.9 million in Q2 2023, down 4.67% quarter-over-quarter from $2.0 million in Q1 2023, and down 16.41% on a YoY basis from $2.2 million in Q2 2022.
Cyclerion Therapeutics (CYCN) Other Non-Current Assets (2018 - 2023) Analysis & Trends
Cyclerion Therapeutics' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $1.9 million for Q2 2023.
- In Q2 2023, Other Non-Current Assets fell 16.41% year-over-year to $1.9 million; the TTM figure through Jun 2023 stood at $1.9 million (down 16.41% YoY), while the FY2022 annual figure was $2.0 million, down 15.21% from the prior year.
- Other Non-Current Assets was $1.9 million for Q2 2023 at Cyclerion Therapeutics, down from $2.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $7.7 million in Q2 2019 to a low of $19000.0 in Q1 2019.
- Historically, Other Non-Current Assets has averaged $3.1 million across 5 years, with a median of $2.4 million in 2021.
- Biggest YoY gain for Other Non-Current Assets was 26168.42% in 2020; the steepest drop was 63.76% in 2020.
- A 5-year view of Other Non-Current Assets shows it stood at $540000.0 in 2019, then soared by 610.56% to $3.8 million in 2020, then tumbled by 37.27% to $2.4 million in 2021, then retreated by 15.21% to $2.0 million in 2022, then decreased by 8.92% to $1.9 million in 2023.
- The last three Other Non-Current Assets figures came in at $1.9 million (Q2 2023), $2.0 million (Q1 2023), and $2.0 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 1.95 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Sep 30, 2022 | 2.13 Mn |
| Jun 30, 2022 | 2.22 Mn |
| Mar 31, 2022 | 2.32 Mn |
| Dec 31, 2021 | 2.41 Mn |
| Jun 30, 2021 | 2.59 Mn |
| Mar 31, 2021 | 2.68 Mn |
| Dec 31, 2020 | 3.84 Mn |
| Sep 30, 2020 | 2.80 Mn |
| Jun 30, 2020 | 4.99 Mn |
| Mar 31, 2020 | 4.99 Mn |
| Dec 31, 2019 | 540,000.00 |
| Sep 30, 2019 | 7.73 Mn |
| Jun 30, 2019 | 7.73 Mn |
| Mar 31, 2019 | 19,000.00 |
| Dec 31, 2018 | 25,000.00 |